Engineering Synthetic Signaling Pathways with Programmable dCas9-Based Chimeric Receptors
暂无分享,去创建一个
[1] F. Balkwill. Tumour necrosis factor and cancer , 2009, Nature Reviews Cancer.
[2] K. Nanjo,et al. Insulin gene mutations and diabetes , 2011, Journal of diabetes investigation.
[3] Daniel Li,et al. CD19 CAR-T cells of defined CD4+:CD8+ composition in adult B cell ALL patients. , 2016, The Journal of clinical investigation.
[4] Quentin R. V. Ferry,et al. Rational design of inducible CRISPR guide RNAs for de novo assembly of transcriptional programs , 2017, Nature Communications.
[5] D. Roberts,et al. Thrombospondin-1 Inhibits VEGF Receptor-2 Signaling by Disrupting Its Association with CD47* , 2010, The Journal of Biological Chemistry.
[6] Feng Zhang,et al. Multidimensional chemical control of CRISPR-Cas9. , 2016, Nature chemical biology.
[7] Eric Reiter,et al. GRKs and beta-arrestins: roles in receptor silencing, trafficking and signaling. , 2006, Trends in endocrinology and metabolism: TEM.
[8] Timothy K Lu,et al. Engineering Synthetic Gene Circuits in Living Cells with CRISPR Technology. , 2016, Trends in biotechnology.
[9] Russell M. Gordley,et al. Engineering Customized Cell Sensing and Response Behaviors Using Synthetic Notch Receptors , 2016, Cell.
[10] Corey W. Liu,et al. Characterization of the FKBP.rapamycin.FRB ternary complex. , 2005, Journal of the American Chemical Society.
[11] T. Wandless,et al. A general chemical method to regulate protein stability in the mammalian central nervous system. , 2010, Chemistry & biology.
[12] Weixian Lu,et al. A time- and cost-efficient system for high-level protein production in mammalian cells. , 2006, Acta crystallographica. Section D, Biological crystallography.
[13] J. Stelling,et al. β-cell–mimetic designer cells provide closed-loop glycemic control , 2016, Science.
[14] P. Darcy,et al. Gene-engineered T cells for cancer therapy , 2013, Nature Reviews Cancer.
[15] Emma Gordon,et al. Mechanisms and regulation of endothelial VEGF receptor signalling , 2016, Nature Reviews Molecular Cell Biology.
[16] L. Claesson‐Welsh,et al. VEGF receptor signalling ? in control of vascular function , 2006, Nature Reviews Molecular Cell Biology.
[17] Tony Pawson,et al. Cell signaling : principles and mechanisms , 2015 .
[18] M. Stack,et al. Tumor production of angiostatin is enhanced after exposure to TNF‐α , 2002, International journal of cancer.
[19] L. Nissim,et al. Multiplexed and programmable regulation of gene networks with an integrated RNA and CRISPR/Cas toolkit in human cells. , 2014, Molecular cell.
[20] S. Munger,et al. Distinct Contributions of T1R2 and T1R3 Taste Receptor Subunits to the Detection of Sweet Stimuli , 2005, Current Biology.
[21] G. Barnea,et al. The genetic design of signaling cascades to record receptor activation , 2008, Proceedings of the National Academy of Sciences.
[22] Tobias M. Fischer,et al. Monitoring regulated protein-protein interactions using split TEV , 2006, Nature Methods.
[23] Willem P C Stemmer,et al. A recombinant polypeptide extends the in vivo half-life of peptides and proteins in a tunable manner , 2009, Nature Biotechnology.
[24] T. Lu,et al. Tunable and Multifunctional Eukaryotic Transcription Factors Based on CRISPR/Cas , 2013, ACS synthetic biology.
[25] David J. Anderson,et al. Visualizing Neuromodulation In Vivo: TANGO-Mapping of Dopamine Signaling Reveals Appetite Control of Sugar Sensing , 2012, Cell.
[26] Alexandro E. Trevino,et al. Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex , 2014, Nature.
[27] Benjamin L. Oakes,et al. Profiling of engineering hotspots identifies an allosteric CRISPR-Cas9 switch , 2016, Nature Biotechnology.
[28] Maria F. Sassano,et al. PRESTO-TANGO: an open-source resource for interrogation of the druggable human GPCR-ome , 2015, Nature Structural &Molecular Biology.
[29] C. June,et al. Going viral: chimeric antigen receptor T‐cell therapy for hematological malignancies , 2015, Immunological reviews.
[30] F. Lienert,et al. Synthetic biology in mammalian cells: next generation research tools and therapeutics , 2014, Nature Reviews Molecular Cell Biology.
[31] S. Libutti,et al. Targeting TNF-α for cancer therapy , 2009, Journal of biology.
[32] S. Riddell,et al. Engineering CAR-T cells: Design concepts. , 2015, Trends in immunology.
[33] Antonia A. Dominguez,et al. Transcriptional regulation of hepatic lipogenesis , 2015, Nature Reviews Molecular Cell Biology.
[34] J. Lawler,et al. Molecular basis for the regulation of angiogenesis by thrombospondin-1 and -2. , 2012, Cold Spring Harbor perspectives in medicine.
[35] James J. Collins,et al. Comparative Analysis of Cas9 Activators Across Multiple Species , 2016, Nature Methods.
[36] Feng Zhang,et al. A split-Cas9 architecture for inducible genome editing and transcription modulation , 2015, Nature Biotechnology.
[37] Wendell A Lim,et al. Complex transcriptional modulation with orthogonal and inducible dCas9 regulators , 2016, Nature Methods.
[38] J. Wess,et al. Engineering GPCR signaling pathways with RASSLs , 2008, Nature Methods.
[39] K. Hristova,et al. VEGFR-2 conformational switch in response to ligand binding , 2016, eLife.
[40] Samuel H Sternberg,et al. Rational design of a split-Cas9 enzyme complex , 2015, Proceedings of the National Academy of Sciences.
[41] Joshua N Leonard,et al. Rewiring human cellular input-output using modular extracellular sensors. , 2017, Nature chemical biology.
[42] Bernd Hauck,et al. Chimeric antigen receptor-modified T cells for acute lymphoid leukemia. , 2013, The New England journal of medicine.
[43] Wendell A. Lim,et al. Designing customized cell signalling circuits , 2010, Nature Reviews Molecular Cell Biology.
[44] B. Levine,et al. Engineered T cells: the promise and challenges of cancer immunotherapy , 2016, Nature Reviews Cancer.
[45] W. Lim,et al. The Principles of Engineering Immune Cells to Treat Cancer , 2017, Cell.
[46] Yuta Nihongaki,et al. Photoactivatable CRISPR-Cas9 for optogenetic genome editing , 2015, Nature Biotechnology.
[47] K. Tye,et al. A light- and calcium-gated transcription factor for imaging and manipulating activated neurons , 2017, Nature Biotechnology.
[48] J. Schlessinger. Cell Signaling by Receptor Tyrosine Kinases , 2000, Cell.
[49] Feng Zhang,et al. Genome engineering using CRISPR-Cas9 system. , 2015, Methods in molecular biology.
[50] G. Mills,et al. The emerging role of lysophosphatidic acid in cancer , 2003, Nature Reviews Cancer.
[51] Eric Reiter,et al. GRKs and β-arrestins: roles in receptor silencing, trafficking and signaling , 2006, Trends in Endocrinology & Metabolism.
[52] Xiaoqiang Guo,et al. Directing cellular information flow via CRISPR signal conductors , 2016, Nature Methods.
[53] H. Horiuchi. Seven-transmembrane receptors , 2015 .
[54] Kole T. Roybal,et al. Engineering T Cells with Customized Therapeutic Response Programs Using Synthetic Notch Receptors , 2016, Cell.
[55] Luke A. Gilbert,et al. Engineering Complex Synthetic Transcriptional Programs with CRISPR RNA Scaffolds , 2015, Cell.
[56] Kole T. Roybal,et al. Precision Tumor Recognition by T Cells With Combinatorial Antigen-Sensing Circuits , 2016, Cell.
[57] Bruce R. Conklin,et al. Ligand-binding domains of nuclear receptors facilitate tight control of split CRISPR activity , 2016, Nature Communications.
[58] Bryan L Roth,et al. G-protein-coupled receptors at a glance , 2003, Journal of Cell Science.
[59] J. Gutkind,et al. G-protein-coupled receptors and cancer , 2007, Nature Reviews Cancer.
[60] C. Lüscher,et al. Temporally precise labeling and control of neuromodulatory circuits in the mammalian brain , 2017, Nature Methods.